Status:
COMPLETED
DuoStim in Cases of PGT: Comparison of Embryo Quantity and Embryonic Quality Using MitoScore
Lead Sponsor:
IVI Madrid
Conditions:
Infertility, Female
Eligibility:
FEMALE
35-42 years
Phase:
NA
Brief Summary
Since preimplantation genetic testing (PGT) is being more frequently requested from patients as women pursue infertility treatments at an advanced age with a poorer prognosis, sometimes physicians are...
Detailed Description
Classically, the follicular development was thought to occur only during the follicular phase of the menstrual cycle. However, new data demonstrated several waves of cyclic development of the antral f...
Eligibility Criteria
Inclusion
- Signed informed consent;
- 35-42 years of age;
- Patients from the IVI Madrid undergoing controlled ovarian hyperstimulation cycle including PGT analysis for infertility treatment;
- BMI 18-30 kg/m2;
- Suspicion of suboptimal or poor response:
- AMH \< 1.5 ng/mL; AFC \< 8; FSH \> 10; Poor response in a previous cycle (defined as \< 6 oocytes).
Exclusion
- Simultaneous participation in another clinical trial or in any other study that could result in a confounding factor.
Key Trial Info
Start Date :
December 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2020
Estimated Enrollment :
136 Patients enrolled
Trial Details
Trial ID
NCT03291821
Start Date
December 1 2017
End Date
June 1 2020
Last Update
December 29 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IVI Madrid
Madrid, Spain, 28035